期刊文献+

奥沙利铂与氟尿嘧啶、亚叶酸钙联合治疗晚期大肠癌 被引量:6

Oxaliplatin combined fluorouracil and calcium folinate in the treatment of 37 cases with advanced colorectal cancer
暂未订购
导出
摘要 目的:研究奥沙利铂与氟尿嘧啶、亚叶酸钙联合应用治疗晚期大肠癌的疗效和毒副反应。方法:采用奥沙利铂130 mg/m^2,静滴2小时,第1天;亚叶酸钙200 mg/m^2,静滴2小时,第1~5天;氟尿嘧啶300 mg/m^2(≤500mg/d),静滴4小时,第1~5天(亚叶酸钙滴完后用);21或28天为1周期。结果:总有效率为29.7%,毒副反应以骨髓抑制、感觉性神经毒性为主,白细胞减少45.9%,Ⅲ级和Ⅳ级为8.1%,感觉性神经毒性81.1%,Ⅲ级和Ⅳ级为5.4%。结论:奥沙利铂与氟尿嘧啶、亚叶酸钙联合应用治疗晚期大肠癌疗效肯定,毒副反应能耐受。 Purpose:To study the response and toxicity of the regimen of oxaliplatin combined with fluorouracil and calcium folinate in the treatment of consisting of advanced colorectal cancer.Methods:Thirty-seven patients with advanced colorectal cancer received chemotherapy of regimen:oxaliplatin 130 mg/m^2 2 hours iv on day 1,calcium folinate 200 mg/ m^2 iv 2 hours on days 1 to 5,followed by fluorouracil 300 mg/m^2(≤500 mg/d) iv 4 h on days 1 to 5,three or four weeks as one cycle.Results:The total response rate was 29.7%,the main toxicity was bone marrow suppression and neuro-sensory toxicity,leukopenia was observed in 45.9% of the patients,but grade Ⅲ and Ⅳ in only 8.1%,neuro-sensory toxicity was observed in 81.9.%,but grade Ⅲ and Ⅳ in only 5.4%.Conclusions:This study shows that the regimen of oxaliplatin combined fluorouracil and calcium folinate is effective and tolerable in advanced colorectal cancer therapy.
出处 《中国癌症杂志》 CAS CSCD 2002年第5期419-420,共2页 China Oncology
关键词 治疗 晚期 大肠癌 奥沙利铂 氟尿嘧啶 亚叶酸钙 化学疗法 疗效 毒副反应 advanced colorectal cancer oxaliplatin fluorouracil calcium folinate
  • 相关文献

参考文献7

  • 1Jennerwein MM,Eastman A,Khokhar A.Characterizotion of adduct produced in DNA by isomeric 1,2-diaminocyclohexane platinum(Ⅱ)complexes[J].Chem Biol Interact,1989,70(1-2);39-49.
  • 2Kraker AJ,Moore CW.Accumulation of cis-diamminedichloroplatinum(Ⅱ) and platinum analogues by platinum-resistant murine leukemia cells in vitro[J].Cancer Res,1988,48(1):9-13.
  • 3Tashiro T,Kowada Y,Sakuria Y,et al.Autitumor activity of a new platinum complexe,oxalato(trains-1-1,2-diamminedichexane) platinum(Ⅱ):new experimental data[J]. Biomed Pharmacother,1989,43(4):251-260.
  • 4Diaz-Rubio E, Ssatre J, Zaniboni A.Oxaliplatin as single agent in previously untreated colorectal carcinoma patients:a phase Ⅱ multicentric study [J].Ann Oncol,1998,9:105-108.
  • 5Becouarn Y,Ychou M,Ducreux M,et al.PhaseⅡtrail of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers[J]. J Clin Oncol,1998,16(8):2739-2744.
  • 6Ducreux M, Louvet C, Bekradda M, et al. Oxaliplatin for the treatment of advanced colorectal cancer: future directions [J].Semin Oncol,1998,25(2 Suppl 5):47-53.
  • 7孙燕,管忠震,金懋林,李维廉,李丽庆,石廷章,周立中,隋广杰,许立功,宋恕平,许德凤,李容,李扬,黄富麟,张嘉庆,张和平,Brienza S,鞠利雅.奥沙利铂单药或与氟尿嘧啶-甲酰四氢叶酸联合应用治疗晚期大肠癌Ⅱ期临床试用报告[J].癌症,1999,18(3):237-240. 被引量:347

二级参考文献2

共引文献346

同被引文献37

  • 1段仁慧,田国防,王天义,张桂芳.奥沙利铂联用氟脲嘧啶与亚叶酸钙治疗晚期结直肠癌的临床观察[J].现代肿瘤医学,2004,12(3):205-206. 被引量:6
  • 2孙燕 周际昌.临床肿瘤内科手册[M].北京:人民卫生出版社,1996.30-33.
  • 3American Cancer Society: Cancer facts and figures 1995[ M ]. Atlanta,GA,American Cancer Society,1995:45.
  • 4Glimelius B, Hoffman K, Graf W, et al; Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer: The Nordic Gastrointestinal Tumor Adjuvant Therapy Group[J]. Cancer, 1994,73 (3) : 556-562.
  • 5de-Gramont A, Vignoud J, Tournigand C, et al: Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic eolorectal cancer[ J ]. Eur J Cancer,1997,33(2):214-219.
  • 6Andre T,louvet C,Raymond E,et al:Bimonthly high-dose leucovorin, 5-fluorouracil 48-hour infusion and oxaliplatin( FOLFOX3 )for metastatic colorectal cancer resistant to the same LV-5FU regimen[J]. Ann Oncol, 1998,9(11) : 1251-1253.
  • 7Lnei F, Zidani R, Vannetzel JM, et al: Chroniomodulated versus fixed infusion rate delivery of ambulatory chemotherapy with oxaliplatin,5-fluorouracil and folinic acid in patients with colorectal cancer metastases: A randomized multinstitutional trials[J]. J Natl Cancer Inst, 1994,86(21) : 1608-1617.
  • 8Tashiro T, Kowada Y, Sakuria Y, et al. Antitumor activity of a new platinum eomplex,oxalato ( trains-1-1,2-diamminedichexane) platinum (Ⅱ) : new experimental data[J]. Biomed Pharmacother,1989,43(4) :251-260.
  • 9Diaz-Rubio E,SSatre J,Zaniboni A. Oxaliplatin as single agent in previously untreated colorectal carcinoma patients:a phase Ⅱ multicentric study[ J ]. Ann Oncol, 1998,9:105-108.
  • 10Duereux M, Louvet C, Bekradda M, et al. Oxaliplatin for the treatment of advanced colorectal cancer; future diections[J]. Semin Oncol, 1998,25(2 Suppl 5) :47-53.

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部